Sharechat Logo

NZX cash trading in January a third higher than in same month of 2012

Tuesday 5th February 2013

Text too small?

Cash market trades on the NZX jumped by 33 percent in January from the same month last year, driven by share transactions.

Total trades rose to 69,281 and the value of trading rose 66 percent to $2.3 billion, NZX said in its monthly shareholder metrics. The average daily value of trading rose 51 percent to $106 million.

The NZX 50 Index has gained 4.4 percent this year and reached a five-year high on Jan. 31, helped by the lure of relatively high dividend yields and demand for stocks from KiwiSaver funds. The market value of stocks on the NZX rose 33 percent to $69 billion last month from a year earlier, amounting to 33 percent of gross domestic product.

Total equity trades rose 35 percent to 67,289 while the value climbed about 68 percent to $2.3 billion. Trades in debt securities fell 14 percent to 1,992 while the value rose 15 percent to $65 million. The value of debt securities on the NZDX fell 7.1 percent to $14.7 billion.

There were 167 equity securities listed on the NZX in January, a 2.9 percent drop from a year earlier. Debt securities fell 9.3 percent to 97.

NZX shares last traded unchanged at $1.33 and have gained 11 percent this year.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report